Sanofi SA
PAR:SAN
Sanofi SA
Operating Income
Sanofi SA
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Sanofi SA
PAR:SAN
|
Operating Income
€10.4B
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-1%
|
|
Ipsen SA
PAR:IPN
|
Operating Income
€590.3m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
1%
|
CAGR 10-Years
10%
|
|
Vetoquinol SA
PAR:VETO
|
Operating Income
€78.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
12%
|
CAGR 10-Years
10%
|
|
Virbac SA
PAR:VIRP
|
Operating Income
€185.2m
|
CAGR 3-Years
15%
|
CAGR 5-Years
20%
|
CAGR 10-Years
6%
|
|
Boiron SA
PAR:BOI
|
Operating Income
€61.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-6%
|
|
Medincell SA
PAR:MEDCL
|
Operating Income
-€24.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
See Also
What is Sanofi SA's Operating Income?
Operating Income
10.4B
EUR
Based on the financial report for Dec 31, 2023, Sanofi SA's Operating Income amounts to 10.4B EUR.
What is Sanofi SA's Operating Income growth rate?
Operating Income CAGR 10Y
-1%
Over the last year, the Operating Income growth was 3%. The average annual Operating Income growth rates for Sanofi SA have been 12% over the past three years , 11% over the past five years , and -1% over the past ten years .